Wednesday February 10 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

BioNews - BioPortfolio's News Portal
Drug Development News and Headlines

Sign-up to BioPortfolio's
Drug Development news alerts.
Subscribe to
Drug RSS feed - - View full RSS Index
Subscribe to BioWatch News Email alerts - open BioWatch PDF brochure.
Publish your news using BioNewsCast - open BioNewsCast PDF brochure.

Theravance said FDA seeks more data for second indication for its drug Vibativ
NW32.com:  similar ...
News from Peregrine Pharmaceuticals highlights the most recent developments
Health & Medicine Week via NewsRx.com:  similar ...
Incyte Cites Encouraging Clinical Data in Multiple Programs; Announces Second Quarter 2007 Financial Results
Business Wire:  similar ...
Daily HIV/Aids Report
Kaisernetwork.org. Distributed by AllAfrica Global Media (allAfrica.com).:  similar ...
Progenics Presents Additional Positive Clinical Results for HIV-Entry Inhibitor PRO 140 at International AIDS Meeting
Business Wire:  similar ...
Positive Opinion for Expanded Label of CUBICIN Received from European Regulatory Authority; Decision Expected This September
Business Wire:  similar ...
, an Investigational Oral HIV Integrase Inhibitor, in Combination Therapy Demonstrated HIV RNA Reduction Comparable to Efavirenz in Treatment-Naive HIV-Positive Patients
Business Wire:  similar ...
BioCryst Initiates Phase II Clinical Trial to Evaluate Intravenous Peramivir in Patients Hospitalized With Influenza
PR Newswire:  similar ...
Presented At International AIDS Society Meeting in Sydney
Business Wire:  similar ...
Pro-Pharmaceuticals Enters Research Agreement with Global Bio-pharmaceutical Company
Business Wire:  similar ...
New Interim Results Demonstrate High Response Rate With FUZEON(R) Plus Darunavir Regardless of Existing Protease Inhibitor Resistance
PR Newswire:  similar ...
DOR BioPharma, Inc. Announces 3 Month Extension of FDA PDUFA Action Date for orBec(R) New Drug Application to Review Supplemental Data
Market Wire, Incorporated:  similar ...
Genentech officials describe the recent activities
Health & Medicine Week via NewsRx.com:  similar ...
New Phase 3 Study Published in the Lancet Evaluates Efficacy and Safety of PREZISTA/ritonavir vs. Kaletra As Part of HIV Combination Therapy in...
Drug Week via NewsRx.com:  similar ...
Switzerland healthcare: Roche's RNAi revolution
Economist Intelligence Unit:  similar ...
Geron Corporation officials report on new developments
Health & Medicine Week via NewsRx.com:  similar ...
MIGENIX Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Canada Newswire Ltd. All Rights Reserved.:  similar ...
DOR BioPharma, Inc. Announces Initiation of orBec(R) Phase 2 GVHD Prophylaxis Clinical Trial
Market Wire, Incorporated:  similar ...
Mpex Pharmaceuticals Initiates Multi-Dose Clinical Trial in the U.S. with MP-376 in Patients with Cystic Fibrosis
PR Newswire:  similar ...
U.S. FDA and European EMEA Accept Registration Applications for Ceftobiprole, Novel Anti-MRSA Broad-Spectrum Cephalosporin
Market Wire, Incorporated:  similar ...

Search BioNews

      ---Advanced searching---

Sign-up to BioPortfolio's Drug Development news alerts.
Subscribe to BioWatch News Email alerts - open BioWatch PDF brochure.
Publish your news using BioNewsCast - open BioNewsCast PDF brochure.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.